Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

So please be patient with us. People are saying, I just want to go look at my house and I want to see what’s left. We know that, but we have people literally looking for the remains of your ...

Nucala (mepolizumab) is a brand-name subcutaneous injection that comes in different forms. Depending on which form you’re prescribed, you or your doctor will administer the injection. Nucala ...

“Following physician and patient experience with Nucala in severe eosinophilic asthma, we are thrilled that the FDA has expanded the use of this medicine to patients with EGPA, another ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with nasal ...

GSK’s Nucala was approved in the US for severe asthma with an eosinophilic phenotype treatment. Credit: MAXSHOT.PL / Shutterstock. The China National Medical Products Administration (NMPA) has ...

El Financiero, BBC News, The Independent, Marca, ABP News, and Newsweek reported on the surge in HMPV patients in China, among other news outlets. In response to the rising cases, the Chinese ...

More NHS patients who need elective care will be able to decide where they are treated under new Government plans to slash waiting lists. The NHS App will be overhauled to give patients more ...

Plans for an upgraded NHS App to allow more patients in England to book treatments and appointments will be part of a package of measures unveiled by the government on Monday. The changes will ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy ...

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...

Patients with symptoms of bowel and lung conditions, cancer and heart failure will be fast-tracked for scans and tests, under government plans to cut NHS waiting times. Under the prime minister ...